New properties of inclusion bodies with implications for biotechnology
- 1 April 2008
- journal article
- Published by Wiley in Biotechnology and Applied Biochemistry
- Vol. 49 (4), 239-246
- https://doi.org/10.1042/ba20070140
Abstract
Human G‐CSF (granulocyte colony‐stimulating factor) is a well‐known biopharmaceutical drug being mostly produced by overexpression in Escherichia coli, where it appears in the form of IBs (inclusion bodies). Following our initial findings that properties of inclusion bodies strongly depend on the growth conditions used, especially growth temperature, we compared the characteristics of the G‐CSF inclusion bodies prepared at two different temperatures, namely 42 and 25 °C. IBs formed at higher growth temperatures have properties similar to the usually described IBs, containing mainly denatured recombinant protein and being almost completely insoluble in aqueous solutions containing mild detergents or low concentrations of denaturants. In contrast, when produced at lower growth temperature of 25 °C, IBs show significantly different properties. Such IBs contain a significant proportion of G‐CSF that is easily and directly extractable in the biologically active form, using non‐denaturing solutions, which can be exploited for environmentally friendly biotechnological production. Irrespective of the production temperature, a significant decrease in IB volume was observed when transferring IBs from neutral to acidic (around 4) pH. Irreversible contraction of IBs at low pH was documented at the macro‐ and micro‐scopic level using electron microscopy as a characterization tool. Together with volume decrease, a higher density, and thus decreased solubility, of IBs was observed at low pH, resulting in slower and less efficient extractability of the target protein.Keywords
This publication has 30 references indexed in Scilit:
- Current status of technical protein refoldingJournal of Biotechnology, 2007
- Structural analysis of protein inclusion bodies by Fourier transform infrared microspectroscopyBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2006
- Kinetics of inclusion body formation studied in intact cells by FT‐IR spectroscopyFEBS Letters, 2005
- Nondenaturing solubilization of β2 microglobulin from inclusion bodies by l-arginineBiochemical and Biophysical Research Communications, 2005
- Solubilization of active green fluorescent protein from insoluble particles by guanidine and arginineBiochemical and Biophysical Research Communications, 2003
- Characterization, Formulation, and Stability of Neupogen® (Filgrastim), a Recombinant Human Granulocyte-Colony Stimulating FactorPublished by Springer Science and Business Media LLC ,2002
- Optimization of Inclusion Body Solubilization and Renaturation of Recombinant Human Growth Hormone from Escherichia coliProtein Expression and Purification, 2000
- Limitedin VivoProteolysis of Aggregated ProteinsBiochemical and Biophysical Research Communications, 1997
- The international standard for granulocyte colony stimulating factor (G-CSF) Evaluation in an international collaborative studyJournal of Immunological Methods, 1995
- In vitro bioassay with enhanced sensitivity for human granulocyte colony-stimulating factorJournal of Pharmaceutical and Biomedical Analysis, 1995